DRGEM Corporation (KOSDAQ:263690)
South Korea
· Delayed Price · Currency is KRW 4,965.00
-185.00 (-3.59%)
At close: Mar 9, 2026
DRGEM Revenue
DRGEM had revenue of 24.36B KRW in the quarter ending September 30, 2025, with 0.19% growth. This brings the company's revenue in the last twelve months to 98.34B, down -12.56% year-over-year. In the year 2024, DRGEM had annual revenue of 104.01B, down -7.89%.
Revenue (ttm)
98.34B
Revenue Growth
-12.56%
P/S Ratio
0.55
Revenue / Employee
366.94M
Employees
268
Market Cap
54.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104.01B | -8.91B | -7.89% |
| Dec 31, 2023 | 112.92B | 2.75B | 2.50% |
| Dec 31, 2022 | 110.17B | 24.41B | 28.47% |
| Dec 31, 2021 | 85.75B | -20.85B | -19.56% |
| Dec 31, 2020 | 106.60B | 46.52B | 77.41% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JPI Healthcare | 52.79B |
| Genoray | 102.75B |
| Neofect | 20.50B |
| Hironic | 33.18B |
| QuantaMatrix | 3.35B |
| Noul Co.,Ltd. | 3.91B |
| UXN Co., Ltd. | 21.18M |
| Genesystem | 345.38M |